Vivimusta

Active Ingredient(s): Bendamustine Hydrochloride
FDA Approved: * December 7, 2022
Pharm Company: * SLAYBACK PHARMA LLC
Category: Cancer

Bendamustine, sold under the brand name Treanda among others, is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma.[2][3] It is given by injection into a vein.[2] Common side effects include low blood cell counts, fever, nausea, diarrhea, loss of appetite, cough, and rash.[2] Other severe side effects include allergic reactions and increased risk of... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vivimusta 25 mg/ml Intravenous Injection
NDC: 71225-120
Labeler:
Slayback Pharma LLC

Related Brands

Drugs with the same active ingredients